BBSRC, with input from the Engineering and Physical Sciences Research Council (EPSRC), has published a document outlining the impacts that their 2010 'Synthetic Biology Dialogue' has had in informing continued discussions around synthetic biology.
Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated in mice a way to prevent this sort of response.
A team of Tel Aviv University researchers, led by Dr. Shimon Rochkind and Prof. Zvi Nevo, has invented a method for repairing damaged peripheral nerves using a biodegradable implant along with a newly-developed gel that increases nerve growth and healing, ultimately restoring function to a torn or damaged nerve. The therapy is only a few years away from clinical use, say the researchers.
The Synthetic Biology ERA-NET (ERASynBio) has announced its 1st joint call for transnational research projects in Synthetic Biology. The call will be open until 26 August 2013 and represents a unique opportunity for Europe and the USA to build Synthetic Biology capacity through innovative transnational projects.
Experiments at Johns Hopkins have unearthed clues about which protein signaling molecules are allowed into hollow, hair-like 'antennae', called cilia, that alert cells to critical changes in their environments.
Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.